Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We got an update on Hill-Rom's business in late October when the company reported strong Q4 results that easily beat expectations.
Third-Quarter Results
Revenue for the period was up 9% from last year to $397 million. Earnings also came in strong at 67 cents, 22% ahead of the Zacks Consensus Estimate, where the company now has an average earnings surprise of 24% over the last four quarters.
Hill-Rom's largest segment, North American Acute Care, saw sales increase 10% from last year to $231 million. The company's International and Surgical division was also strong, up 14% from last year to $118 million.
Hill-Rom also scored big in a few key categories, with its operating margin expanding to 16.4% from 10.7% last year and operating cash flow increasing to $79 million.
Strong Balance Sheet
The company emerged from the quarter with its strong balance sheet in tact, with cash and equivalents of $184.5 million against total debt of $152 million, down $50 million from last year. Estimates
We saw some pretty solid movement in estimates on the good quarter, with the current year adding 21 cents to $2.13 and the next-year estimate gaining 21 cents to $2.39, a bullish 12% growth projection.
Valuation
But in spite of the gains, the valuation picture still looks reasonable at 18X forward earnings, in line with the industry average of 19X.
2-Year Chart
HRC recently hit a new all-time high after jumping on the good quarter. But in spite of the gains, the stochastic below the chart is signaling that shares are trading well away from over-bought territory. Look for support from the long-term trend on any weakness, take a look below.
Read the Aug 18 HRC article here
Last Week's Momentum Zacks Rank Buy Stocks
Ctrip.com International, Ltd. (CTRP) recently hit a new multi-year high above $53 after the company reported an awesome Q3 earnings surprise of 29% in early November. With a bullish next-year estimate and high industry rank, this Zacks #1 rank stock provides international flavor to the momentum faction. Read Full Article.
Whole Foods Market, Inc. (WFMI) recently jumped to a new multi-year high after reporting strong Q4 results that included an 18% earnings surprise. With an average earnings surprise of 18% over the last four quarters and bullish 13% next-year growth projection, this Zacks #1 rank stock offers a healthy serving of momentum. Read Full Article.
Sotheby's (BID) recently hit a new multi-year high at $47.23 after reporting a solid 31% Q3 earnings surprise in early November. Estimates have since jumped higher, with the next-year estimate projecting 17% growth, providing plenty of momentum for this Zacks #1 rank stock. Read Full Article.
Steve Madden Ltd. (SHOO) recently hit a new all-time high at $44.85 before reporting solid Q3 results that included a 5% earnings surprise. With an average earnings surprise of 14% over the last four quarters and a bullish growth projection, SHOO is kicking up the momentum meter a notch or two. Read Full Article.
Michael Vodicka is the Momentum Stock Strategist for Zacks.com. He is also the Editor in charge of the new Zacks Momentum Trader Service.
Read the full Snapshot Report on HRC